scholarly article | Q13442814 |
P356 | DOI | 10.1080/02791072.2003.10400021 |
P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.1080/02791072.2003.10400021 |
P698 | PubMed publication ID | 14621136 |
P2093 | author name string | Wayne Briner | |
Mark Mowry | |||
Michael Mosher | |||
P2860 | cites work | Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland. | Q33913584 |
Salvia divinorum and salvinorin A: new pharmacologic findings | Q34292784 | ||
Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum | Q56135973 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | general psychology | Q1361345 |
P304 | page(s) | 379-382 | |
P577 | publication date | 2003-07-01 | |
P1433 | published in | Journal of Psychoactive Drugs | Q6295808 |
P1476 | title | Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A | |
P478 | volume | 35 |
Q30357121 | A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist. |
Q43842140 | Acute and post-acute behavioral and psychological effects of salvinorin A in humans |
Q33269030 | Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement |
Q34949512 | Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum |
Q34632744 | Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats. |
Q34451886 | New drugs of abuse |
Q33725088 | Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace |
Q37113859 | Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds |
Q44350288 | Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates |
Q34939810 | Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A |
Q24656590 | Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents |
Q44641835 | Salvia divinorum use and phenomenology: results from an online survey |
Q38652778 | Salvia divinorum: An overview of the usage, misuse, and addiction processes |
Q64062550 | Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action |
Q28481482 | Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in piglets |
Q34820974 | Salvinorin A decreases mortality and improves neurological outcome in a neonatal mouse hypoxia model |
Q34510909 | Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors |
Q34514502 | The pharmacological effects of Salvia species on the central nervous system |
Search more.